MedPath

Randomised comparative trial of Bupivacaine and 2-Chloroprocaine by caesarean section.

Conditions
C-section, Chloroprocaine, intrathecal, Bupivacaine, caesarean, Sufentanil, Ampres, Marcaine.
Registration Number
NL-OMON22342
Lead Sponsor
Z BrusselLaarbeeklaan 1011090 Jette
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

All healthy(ASA I-II) women with an uncomplicated singleton pregnancy between 18-40 y undergoing a planned caesarian.

Pregnancy > or equal to 37 weeks.

Exclusion Criteria

Women who belong to ASA III-IV classification, BMI >35, length <150 cm, foetus with known fetal abnormality, pregnancy less than 37 weeks, known allergy for the used local anesthetics and (pre) eclampsia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Earlier releave of motor block (less then 90' after injection).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath